BioCentury
ARTICLE | Clinical News

Amunix, Versartis preclinical data

October 5, 2009 7:00 AM UTC

In a mouse model of obesity, monthly VRS-859 resulted in weight loss comparable to twice-daily exenatide. Pharmacokinetic studies in mice, rats, dogs and monkeys support 100 mg VRS-859 as a monthly do...